Moreover, EPO/EPOR promoted tumorigenesis in genetically engineered mouse models of breast cancer by activating JAK/STAT signaling in breast tumor-initiating cells (TICs) and promoted its self-renewal. The gene discussed is EPO; the disease is breast carcinoma.